Indications for an ICD

Revision as of 16:21, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Indications for an ICD

Articles

Most recent articles on Indications for an ICD

Most cited articles on Indications for an ICD

Review articles on Indications for an ICD

Articles on Indications for an ICD in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Indications for an ICD

Images of Indications for an ICD

Photos of Indications for an ICD

Podcasts & MP3s on Indications for an ICD

Videos on Indications for an ICD

Evidence Based Medicine

Cochrane Collaboration on Indications for an ICD

Bandolier on Indications for an ICD

TRIP on Indications for an ICD

Clinical Trials

Ongoing Trials on Indications for an ICD at Clinical Trials.gov

Trial results on Indications for an ICD

Clinical Trials on Indications for an ICD at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Indications for an ICD

NICE Guidance on Indications for an ICD

NHS PRODIGY Guidance

FDA on Indications for an ICD

CDC on Indications for an ICD

Books

Books on Indications for an ICD

News

Indications for an ICD in the news

Be alerted to news on Indications for an ICD

News trends on Indications for an ICD

Commentary

Blogs on Indications for an ICD

Definitions

Definitions of Indications for an ICD

Patient Resources / Community

Patient resources on Indications for an ICD

Discussion groups on Indications for an ICD

Patient Handouts on Indications for an ICD

Directions to Hospitals Treating Indications for an ICD

Risk calculators and risk factors for Indications for an ICD

Healthcare Provider Resources

Symptoms of Indications for an ICD

Causes & Risk Factors for Indications for an ICD

Diagnostic studies for Indications for an ICD

Treatment of Indications for an ICD

Continuing Medical Education (CME)

CME Programs on Indications for an ICD

International

Indications for an ICD en Espanol

Indications for an ICD en Francais

Business

Indications for an ICD in the Marketplace

Patents on Indications for an ICD

Experimental / Informatics

List of terms related to Indications for an ICD

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]

Cardiology Network

Discuss Indications for an ICD further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Template:WikiDoc Cardiology News


Class I

1. Cardiac arrest due to ventricular fibrillation (VF) or ventricular tachycardia (VT) not due to a transient or reversible cause. (Level of evidence: A)

2. Spontaneous sustained VT in association with structural heart disease. (Level of evidence: B)

3. Syncope of undetermined origin with clinically relevant, hemodynamically significant sustained VT or VF induced at electrophysiologic study when drug therapy is ineffective, not tolerated, or not preferred. (Level of evidence: B)

4. Nonsustained VT in patients with coronary artery disease, prior myocardial infarction (MI), left ventricular (LV) dysfunction, and inducible VF or sustained VT at electrophysiologic study that is not suppressible by a Class I antiarrhythmic agent. (Level of evidence: A)

5. Spontaneous sustained VT in patients who do not have structural heart disease that is not amenable to other treatments. (Level of evidence: C)

Class IIa

1. Patients with LV ejection fraction of 30% or less, at least 1 month post-MI and 3 months post coronary artery revascularization surgery. (Level of evidence: B)

Class IIb

1. Cardiac arrest presumed to be due to VF when electrophysiologic testing is precluded by other medical conditions. (Level of evidence: C)

2. Severe symptoms (eg, syncope) attributable to sustained ventricular tachyarrhythmias in patients awaiting cardiac transplantation. (Level of evidence: C)

3. Familial or inherited conditions with a high risk for life threatening ventricular tachyarrhythmias, such as long QT syndrome or hypertrophic cardiomyopathy. (Level of evidence: B)

4. Nonsustained VT with coronary artery disease, prior MI, LV dysfunction, and inducible sustained VT or VF at electrophysiologic study. (Level of evidence: B)

5. Recurrent syncope of undetermined etiology in the presence of ventricular dysfunction and inducible ventricular arrhythmias at electrophysiologic study when other causes of syncope have been excluded. (Level of evidence: C)

6. Syncope of unexplained etiology or family history of unexplained sudden cardiac death in association with typical or atypical right bundle-branch block and ST-segment elevations (Brugada syndrome). (Level of evidence: C)

7. Syncope in patients with advanced structural heart disease in which thorough invasive and noninvasive investigation has failed to define a cause. (Level of evidence: C)

Class III

1. Syncope of undetermined cause in a patient without inducible ventricular tachyarrhythmias and without structural heart disease. (Level of evidence: C)

2. Incessant VT or VF. (Level of evidence: C)

3. VT or VF resulting from arrhythmias amenable to surgical or catheter ablation; for example, atrial arrhythmias associated with the Wolff-Parkinson-White syndrome, right ventricular outflow tract VT, idiopathic LV tachycardia, or fascicular VT. (Level of evidence: C)

4. Ventricular tachyarrhythmias due to a transient or reversible disorder (eg, acute MI, electrolyte imbalance, drugs, or trauma) when correction of the disorder is considered feasible and likely to substantially reduce the risk of recurrent arrhythmia. (Level of evidence: B)

5. Significant psychiatric illnesses that may be aggravated by device implantation or may preclude systematic follow-up. (Level of evidence: C)

6. Terminal illnesses with projected life expectancy of 6 months or less. (Level of evidence: C)

7. Patients with coronary artery disease, LV dysfunction, and prolonged QRS duration in the absence of spontaneous or inducible sustained or nonsustained VT who are undergoing coronary bypass surgery. (Level of evidence: B)

8. NYHA Class 4 drug-refractory congestive heart failure in patients who are not candidates for cardiac transplantation. (Level of evidence: C)

Template:WikiDoc Sources

Template:Mdr